WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.
Ucom Supports Coca-Cola Fest 2026
“Orran” Students Start the New Academic Year with Support from “The Power of One Dram”
Harutyun Harutyunyan: “The Government Has No Intention of Applying for EU Membership
and Adopted th...
All Armflix Content Is Once Again Available on Uplay
The Unprecedented Educational Summer of the 'Armenian Virtuosos'
Hayk Melikyan Opens the 5th Festival of Armenian Culture in Katowice
Become a Unibank shareholder and acquire perpetual bonds with a 13.25% yield
EBRD’s AMD-denominated bonds listed on AMX; Converse Bank acted as underwriter
Ucom Continues Large-Scale Network Modernization, Expanding 5G Coverage and Enhancing Connectivity